Small molecule inhibition of RNA binding proteins in haematologic cancer

In recent years, advances in biomedicine have revealed an important role for post-transcriptional mechanisms of gene expression regulation in pathologic conditions. In cancer in general and leukaemia specifically, RNA binding proteins have emerged as important regulator of RNA homoeostasis that are often dysregulated in the disease state. Having established the importance of these pathogenetic mechanisms, there have been a number of efforts to target RNA binding proteins using oligonucleotide-based strategies, as well as with small organic molecules. The field is at an exciting inflection point with the convergence of biomedical knowledge, small molecule screening strategies and improved chemical methods for synthesis and construction of sophisticated small molecules. Here, we review the mechanisms of post-transcriptional gene regulation, specifically in leukaemia, current small-molecule based efforts to target RNA binding proteins, and future prospects.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

RNA biology - 21(2024), 1 vom: 10. Jan., Seite 1-14

Sprache:

Englisch

Beteiligte Personen:

Jaiswal, Amit K [VerfasserIn]
Thaxton, Michelle L [VerfasserIn]
Scherer, Georgia M [VerfasserIn]
Sorrentino, Jacob P [VerfasserIn]
Garg, Neil K [VerfasserIn]
Rao, Dinesh S [VerfasserIn]

Links:

Volltext

Themen:

63231-63-0
Acute leukaemia
Drug discovery
Journal Article
Post-transcriptional gene regulation
RNA
RNA binding proteins
RNA splicing
RNA-Binding Proteins
Review

Anmerkungen:

Date Completed 09.02.2024

Date Revised 11.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/15476286.2024.2303558

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368183688